← Back to contracts

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

US · MD National Institutes of Health (NIH) grant open #PAR-25-103
Response due Oct 25, 2027 · 00:00 UTC

Summary

The National Institutes of Health (NIH) is offering a funding opportunity under the Cancer Prevention and Control Clinical Trials Planning Grant Program (U34). This program supports planning activities for clinical trials focused on cancer prevention and control. The U34 mechanism is designed to fund the developmental and planning work needed before a full-scale clinical trial is launched. Clinical trials are optional under this announcement, allowing flexibility in the type of research activities supported during the planning phase.

What they want

Fund planning and developmental activities preparatory to the conduct of clinical trials in cancer prevention and control. The U34 cooperative agreement mechanism supports the work required to design, pilot, and prepare a full clinical trial protocol. Clinical trials are optional under this announcement (PAR-25-103), meaning applicants may propose either clinical trial or non-clinical trial planning activities within the cancer prevention and control domain.

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

  • Extremely long open window (nearly 3 years, Nov 2024 – Oct 2027) may result in rolling competition with shifting priorities
  • Minimal detail provided in the synopsis — full program announcement should be reviewed for hidden eligibility restrictions or preference criteria

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541714
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Cancer Prevention and Control Clinical Tri…
Due Oct 25
Onboard